Anaïs Fauche is a seasoned professional in the fields of regulatory affairs and science education, currently serving as an Evaluator at the AFMPS since November 2018, focusing on medical devices and the proper use of medicines. Previous roles include a regulatory affairs trainee at GSK and a high school science teacher, where mentorship and compliance with educational standards were key responsibilities. Anaïs has a solid research background, having worked as a research assistant at the Behavioural Ecology Research Group at the University of Oxford. Anaïs holds a Master’s degree in "Science, Technology, Health" from Université de Bourgogne and has obtained various certifications in regulatory affairs and clinical trial design, enhancing expertise in both scientific research and regulatory compliance.
FAMHP - Federal Agency for Medicines and Health Products
The Federal Agency for Medicines and Health Products (FAMHP) is the Belgian competent authority in charge of ensuring the quality, safety and efficacy of medicines and health products (medical devices and accessories, raw materials, blood and blood products of human origin, human tissue material), for human and veterinary use, in clinical development and on the market. The famhp works together with the academic world, the pharmaceutical industry and the other industries concerned, healthcare professionals, other national, European and worldwide authorities, as well as policy makers, in order to provide everybody with the necessary medicines and health products and to help patients and citizens to use them correctly. The famhp has grown since its creation from an organization with a few dozen employees to an agency that has more than 500 employees which are mostly scientifically trained. The agency consists out of five entities: three Directorates-General, DG PRE authorisation, DG POST authorisation and DG INSPECTION, the support services and the CEO Services.